Cargando…
Chinese patent herbal medicine (Shufeng Jiedu capsule) for acute upper respiratory tract infections: A systematic review and meta-analysis
Background: Shufeng Jiedu capsule has been widely used in China for acute upper respiratory tract infections (AURTIs). The aim of this study was to evaluate its effectiveness and safety for AURTIs. Methods: Randomized controlled trials comparing SFJD with conventional drug for patients with AURTIs w...
Autores principales: | Zhang, Ying-ying, Xia, Ru-yu, Liang, Shi-bing, Hu, Xiao-yang, Dai, Meng-yuan, Li, Yi-lin, Zhao, Le-yi, Moore, Michael, Fei, Yu-tong, Liu, Jian-ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8099504/ https://www.ncbi.nlm.nih.gov/pubmed/33996460 http://dx.doi.org/10.1016/j.imr.2021.100726 |
Ejemplares similares
-
Study on basic and clinical application of Shufeng Jiedu Capsule in treating respiratory tract infection
por: Han, Yanqi, et al.
Publicado: (2023) -
Chinese Patent Medicine Shufeng Jiedu Capsules as an Adjuvant Therapy for Community-Acquired Pneumonia: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
por: Zhang, Xiao-Wen, et al.
Publicado: (2022) -
Shufeng Jiedu capsules for treating acute exacerbations of chronic obstructive pulmonary disease: a systematic review and meta-analysis
por: Xia, Ru-yu, et al.
Publicado: (2020) -
Analysis of the mechanism of Shufeng Jiedu capsule prevention and treatment for COVID-19 by network pharmacology tools
por: Xiong, Haijun, et al.
Publicado: (2020) -
Investigating the mechanism of ShuFeng JieDu capsule for the treatment of novel Coronavirus pneumonia (COVID-19) based on network pharmacology
por: Chen, Xiao, et al.
Publicado: (2020)